Clinical Chemistry · 2004 · 53 citations · 26 references
Life SciencesGeneticsMolecular GeneticsGenomicsHuman GeneticsPharmacogeneticsPharmacogenetic TestingPharmacogenomic TestingVariant AnalysisVariant DetectionAllele-specific DetectionCytochrome P450 2B6Cytochrome P450 Genetic PolymorphismCytochrome P450 GenotypingMultiplex Polymerase Chain Reaction (Pcr)Single-nucleotide Polymorphism AnalysisSingle-nucleotide Polymorphism VariationSingle-nucleotide Polymorphisms
BACKGROUND: Cytochrome P450 2B6 (CYP2B6) has a role in the metabolism of many clinically important substances, but the variation within the CYP2B6 gene has not been fully characterized. The aim of the present study was to develop a reliable and robust assay for determining genotypic variants. METHODS: We used a two-stage procedure. An initial multiplex PCR reaction amplified the relevant gene fragments in exonic and regulatory regions to ensure isolation of CYP2B6 from its similar pseudogene (CYP2B7). This product was then genotyped by allele-specific PCR. RESULTS: The assay detected the following published single-nucleotide polymorphisms: C64T (Arg22Cys), C78T, G216C, G516T (Gln172His), C777A (Ser259Arg), A785G (Lys262Arg), and C1459T (Arg487Cys), as well as additional loci found within the single-nucleotide polymorphism (SNP) databases: A1190G, C1268A, C1330T, A1382G, A1402T, and an A/T SNP in intron 2 (A12917T). This approach detected all common, previously reported alleles and identified a new allele (CYP2B6*4C) present in 2.2% of a Caucasian population. Genotypic frequencies obtained were consistent with previously published results. CONCLUSIONS: This method is simple, reliable, rapid, and amenable to automation and could facilitate the large-scale genotypic analysis of CYP2B6.
26
Multiplex PCR: Critical Parameters and Step-by-Step Protocol
Octavian Henegariu, Nyla A. Heerema, S. R. Dlouhy et al. · BioTechniques · 1997 · 938 citations · Full text